Radioimmunoassay of bleomycin
- PMID: 56999
Radioimmunoassay of bleomycin
Abstract
A radioimmunoassay for bleomycin has been produced using 125l-labeled bleomycin and antisera raised in rabbits against a carbodiimide-catalyzed bleomycin-bovine serum albumin conjugate. 125l-Labeled bleomycin was synthesized by direct iodination of the drug using the chloramine-T technique. The standard curve of the assay was linear on a logit-log plot and the lower limit of sensitivity was 250 pg bleomycin sulfate. A mean recovery of 102.6% (+/- 3.3% S.E.) was obtained using bleomycin added to normal sera. No significant decrease in bleomycin immunoreactivity was observed following 24 hr incubation of the drug in serum at 37 degrees. The radioimmunoassay was also suitable for measuring bleomycin in the presence of other drugs since the assay was not significantly affected by the other antineoplastic agents tested. The sensitivity and specificity of the radioimmunoassay for bleomycin should provide a new means for pharmacokinetic and toxicity studies of bleomycin.
Similar articles
-
Enzyme immunoassay for pepleomycin, a new bleomycin analog.Cancer Res. 1981 Oct;41(10):4121-6. Cancer Res. 1981. PMID: 6169433
-
Development and application of a radioimmunoassay for pepleomycin.Cancer Treat Rep. 1982 Jun;66(6):1365-70. Cancer Treat Rep. 1982. PMID: 6177409
-
A radioimmunoassay for bleomycin.J Nucl Med. 1977 Mar;18(3):296-9. J Nucl Med. 1977. PMID: 65461
-
Radioimmune assay and characteristics of antibodies to macromomycin (NSC 170105).Cancer Res. 1977 Apr;37(4):1197-204. Cancer Res. 1977. PMID: 844045
-
Specificity of antisera produced against bleomycin.Cancer Treat Rep. 1977 Nov;61(8):1509-12. Cancer Treat Rep. 1977. PMID: 72602
Cited by
-
Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.Br J Cancer. 1980 Apr;41(4):644-7. doi: 10.1038/bjc.1980.110. Br J Cancer. 1980. PMID: 6155927 Free PMC article.
-
Clinical pharmacology of the anticancer polypeptide neocarzinostatin.Cancer Chemother Pharmacol. 1983;10(3):200-4. doi: 10.1007/BF00255763. Cancer Chemother Pharmacol. 1983. PMID: 6222845
-
Bleomycin pharmacokinetics in man. I. Intravenous administration.Cancer Chemother Pharmacol. 1978;1(3):177-81. doi: 10.1007/BF00253118. Cancer Chemother Pharmacol. 1978. PMID: 86392 No abstract available.
-
Mechanisms of bleomycin-induced lung damage.Arch Toxicol. 1991;65(2):81-94. doi: 10.1007/BF02034932. Arch Toxicol. 1991. PMID: 1711838 Review.
-
High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture.Cancer Chemother Pharmacol. 1991;28(1):22-6. doi: 10.1007/BF00684951. Cancer Chemother Pharmacol. 1991. PMID: 1710176
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources